在癌症中CD73的临床意义
Niklas Bach1, Riekje Winzer1, Eva Tolosa1
1Department of Immunology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
International journal of molecular sciences
|July 29, 2023
概括
CD73是一种产生免疫抑制腺素的酶,是癌症免疫治疗的有希望的标. 抑制CD73可能会增强抗癌治疗,改善患者的预后.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- CD73是纯能信号传递中的关键酶,产生免疫抑制性腺.
- 瘤中CD73表达升高,与预后不佳和治疗耐药性相关.
- 由CD73产生的腺素阻碍了抗瘤免疫反应,促进了癌症的进展.
研究的目的:
- 审查在癌症免疫治疗中针对CD73的理由.
- 探索CD73抑制作为克服治疗耐药性的战略.
- 讨论CD73作为癌症预后标记物的作用.
主要方法:
- 对CD73抑制剂的临床前和临床研究的文献综述.
- 分析CD73在免疫抑制和癌症促进中的作用.
- 检查CD73的表达模式和预后意义.
主要成果:
- 在临床前模型中,CD73抑制显示出抗癌活性.
- CD73上调是各种癌症治疗中常见的抵抗机制.
- 临床研究正在评估组合疗法中的CD73抑制剂.
结论:
- 抑制CD73是一种有前途的方法,可以提高癌症免疫疗法的疗效.
- CD73 作为癌症潜在的预后生物标志物.
- 向CD73可以克服对化疗,放射治疗和免疫治疗的耐药性.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


